{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:59:45Z","timestamp":1792011585613,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00417-013-2409-1","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T04:52:33Z","timestamp":1374209553000},"page":"35-42","source":"Crossref","is-referenced-by-count":39,"title":["The effect of intravitreal bevacizumab injection as the initial treatment for Coats\u2019 disease"],"prefix":"10.1007","volume":"252","author":[{"given":"Xiao-Xue","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Rong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,20]]},"reference":[{"key":"2409_CR1","first-page":"440","volume":"17","author":"G Coats","year":"1908","unstructured":"Coats G (1908) Forms of retinal disease with massive exudation. Royal London Ophthalmic Hosp Rep 17:440\u2013525","journal-title":"Royal London Ophthalmic Hosp Rep"},{"key":"2409_CR2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9394(01)00896-0","volume":"131","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL, Honavar SG, Demirci H, Cater J (2001) Classification and management of Coats disease: the 2000 Proctor Lecture. Am J Ophthalmol 131:572\u2013583","journal-title":"Am J Ophthalmol"},{"key":"2409_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9394(00)00883-7","volume":"131","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL, Honavar SG, Demirci H (2001) Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol 131:561\u2013571","journal-title":"Am J Ophthalmol"},{"key":"2409_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0301-4738.60081","volume":"58","author":"P Rishi","year":"2010","unstructured":"Rishi P, Rishi E, Uparkar M, Sharma T, Gopal L, Bhende P, Bhende M, Sen PR, Sen P (2010) Coats\u2019 disease: an Indian perspective. Indian J Ophthalmol 58:119\u2013124","journal-title":"Indian J Ophthalmol"},{"key":"2409_CR5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ophtha.2004.12.038","volume":"112","author":"LM Smithen","year":"2005","unstructured":"Smithen LM, Brown GC, Brucker AJ, Yannuzzi LA, Klais CM, Spaide RF (2005) Coats\u2019 disease diagnosed in adulthood. Ophthalmology 112:1072\u20131078","journal-title":"Ophthalmology"},{"key":"2409_CR6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0301-4738.58482","volume":"58","author":"M Entezari","year":"2010","unstructured":"Entezari M, Ramezani A, Safavizadeh L, Bassirnia N (2010) Resolution of macular edema in Coats\u2019 disease with intravitreal bevacizumab. Indian J Ophthalmol 58:80\u201382","journal-title":"Indian J Ophthalmol"},{"key":"2409_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/IAE.0b013e3181c2e0b7","volume":"30","author":"CJ Lin","year":"2010","unstructured":"Lin CJ, Hwang JF, Chen YT, Chen SN (2010) The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina 30:617\u2013622","journal-title":"Retina"},{"issue":"3","key":"2409_CR8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bjophthalmol-2012-302250","volume":"97","author":"R Ray","year":"2013","unstructured":"Ray R, Baranano DE, Hubbard GB (2013) Treatment of Coats\u2019 disease with intravitreal bevacizumab. Br J Ophthalmol 97(3):272\u2013277","journal-title":"Br J Ophthalmol"},{"key":"2409_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/IAE.0b013e318203c01e","volume":"31","author":"JR Wells","year":"2011","unstructured":"Wells JR, Hubbard GB 3rd (2011) The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina 31:427\u2013428","journal-title":"Retina"},{"key":"2409_CR10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00417-010-1563-y","volume":"249","author":"T Zhao","year":"2011","unstructured":"Zhao T, Wang K, Ma Y, Jiang YR (2011) Resolution of total retinal detachment in Coats\u2019 disease with intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol 249:1745\u20131746","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2409_CR11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/jop.2011.0168","volume":"28","author":"H Zhang","year":"2012","unstructured":"Zhang H, Liu ZL (2012) Increased nitric oxide and vascular endothelial growth factor levels in the aqueous humor of patients with Coats\u2019 disease. J Ocul Pharmacol Ther 28:397\u2013401","journal-title":"J Ocul Pharmacol Ther"},{"key":"2409_CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1167\/iovs.12-10613","volume":"54","author":"S Kase","year":"2013","unstructured":"Kase S, Rao NA, Yoshikawa H, Fukuhara J, Noda K, Kanda A, Ishida S (2013) Expression of vascular endothelial growth factor in eyes with Coats\u2019 disease. Invest Ophthalmol Vis Sci 54:57\u201362","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2409_CR13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1091-8531(98)90034-9","volume":"2","author":"AS Budning","year":"1998","unstructured":"Budning AS, Heon E, Gallie BL (1998) Visual prognosis of Coats\u2019 disease. J AAPOS 2:356\u2013359","journal-title":"J AAPOS"},{"key":"2409_CR14","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/archopht.1995.01100120068012","volume":"113","author":"LP Aiello","year":"1995","unstructured":"Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA (1995) Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113:1538\u20131544","journal-title":"Arch Ophthalmol"},{"key":"2409_CR15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3109\/02713683.2012.661114","volume":"37","author":"J Zhou","year":"2012","unstructured":"Zhou J, Wang S, Xia X (2012) Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res 37:416\u2013420","journal-title":"Curr Eye Res"},{"key":"2409_CR16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archophthalmol.2010.227","volume":"128","author":"JB Jonas","year":"2010","unstructured":"Jonas JB, Tao Y, Neumaier M, Findeisen P (2010) Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 128:1281\u20131286","journal-title":"Arch Ophthalmol"},{"key":"2409_CR17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/IAE.0b013e3181d5e964","volume":"30","author":"Y Tao","year":"2010","unstructured":"Tao Y, Jonas JB (2010) Intravitreal bevacizumab for exudative age-related macular degeneration: effect on different subfoveal membranes. Retina 30:1426\u20131431","journal-title":"Retina"},{"key":"2409_CR18","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00417-008-0914-4","volume":"246","author":"S Moradian","year":"2008","unstructured":"Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, Azarmina M (2008) Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 246:1699\u20131705","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2409_CR19","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00417-010-1366-1","volume":"248","author":"YG He","year":"2010","unstructured":"He YG, Wang H, Zhao B, Lee J, Bahl D, McCluskey J (2010) Elevated vascular endothelial growth factor level in Coats\u2019 disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol 248:1519\u20131521","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2409_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3341\/kjo.2010.24.6.374","volume":"24","author":"J Kim","year":"2010","unstructured":"Kim J, Park KH, Woo SJ (2010) Combined photodynamic therapy and intravitreal bevacizumab injection for the treatment of adult Coats\u2019 disease: a case report. Korean J Ophthalmol 24:374\u2013376","journal-title":"Korean J Ophthalmol"},{"key":"2409_CR21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1755-3768.2008.01253.x","volume":"87","author":"PK Stergiou","year":"2009","unstructured":"Stergiou PK, Symeonidis C, Dimitrakos SA (2009) Coats\u2019 disease: treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol 87:687\u2013688","journal-title":"Acta Ophthalmol"},{"key":"2409_CR22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2011-300141","volume":"96","author":"A Ramasubramanian","year":"2012","unstructured":"Ramasubramanian A, Shields CL (2012) Bevacizumab for Coats\u2019 disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol 96:356\u2013359","journal-title":"Br J Ophthalmol"},{"key":"2409_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","volume":"92","author":"JF Arevalo","year":"2008","unstructured":"Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, Eid Farah M, Pieramici DJ, Berrocal MH, Sanchez JG (2008) Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92:213\u2013216","journal-title":"Br J Ophthalmol"},{"key":"2409_CR24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","volume":"246","author":"S Honda","year":"2008","unstructured":"Honda S, Hirabayashi H, Tsukahara Y, Negi A (2008) Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246:1061\u20131063","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2409_CR25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3928\/15428877-20100924-01","volume":"42","author":"JC Hwang","year":"2011","unstructured":"Hwang JC, Del Priore LV, Freund KB, Chang S, Iranmanesh R (2011) Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 42:6\u201311","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"2409_CR26","doi-asserted-by":"crossref","first-page":"e2675","DOI":"10.1371\/journal.pone.0002675","volume":"3","author":"EJ Kuiper","year":"2008","unstructured":"Kuiper EJ, Van Nieuwenhoven FA, de Smet MD, van Meurs JC, Tanck MW, Oliver N, Klaassen I, Van Noorden CJ, Goldschmeding R, Schlingemann RO (2008) The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS One 3:e2675","journal-title":"PLoS One"},{"key":"2409_CR27","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1167\/iovs.10-5669","volume":"51","author":"EC O\u2019Neill","year":"2010","unstructured":"O\u2019Neill EC, Qin Q, Van Bergen NJ, Connell PP, Vasudevan S, Coote MA, Trounce IA, Wong TT, Crowston JG (2010) Antifibrotic activity of bevacizumab on human Tenon\u2019s fibroblasts in vitro. Invest Ophthalmol Vis Sci 51:6524\u20136532","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2409_CR28","first-page":"753","volume":"22","author":"M Karatay","year":"2012","unstructured":"Karatay M, Erdem Y, Koktekir E, Erkoc YS, Caydere M, Bayar MA (2012) The effect of bevacizumab on spinal epidural fibrosis in a postlaminectomy rat model. Turk Neurosurg 22:753\u2013757","journal-title":"Turk Neurosurg"},{"key":"2409_CR29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000310576","volume":"209","author":"T Kubota","year":"1995","unstructured":"Kubota T, Kurihara K, Ishibashi T, Inomata H (1995) Proliferative vitreoretinopathy in Coats\u2019 disease. Clinicohistopathological case report. Ophthalmologica 209:44\u201346","journal-title":"Ophthalmologica"},{"key":"2409_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000323616","volume":"2","author":"G Muftuoglu","year":"2011","unstructured":"Muftuoglu G, Gulkilik G (2011) Pars plana vitrectomy in advanced Coats\u2019 disease. Case Rep Ophthalmol 2:15\u201322","journal-title":"Case Rep Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-013-2409-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2409-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:48:27Z","timestamp":1559072907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-013-2409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,20]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2409"],"URL":"https:\/\/doi.org\/10.1007\/s00417-013-2409-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,20]]}}}